Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oxford Immunotec Edges Closer To Transplant Product Launch

Executive Summary

Oxford Immunotec has set its sights on a 2017 launch for two new immune-response tests emerging from its T-spot platform, on the back of interim results from a major clinical study due at the end of Q1.

You may also be interested in...



Oxford Immunotec Hires Koski To Forge Investor Ties

Oxford Immunotec has appointed Karen Koski as its head of strategy and investor relations. Koski joins the company as it prepares to launch this year two new tests from its T-spot platform.

Oxford Immunotec Bulks Up Immunology Dx Offering

Oxford Immunotec, an immunology-focused diagnostics company, has acquired US company Immunetics.

Specialists Advocate Helmet Ventilation For COVID-19 Hospital Treatment

Experts from the University of Chicago are advocating for helmet ventilation for COVID-19 patients. Medtech Insight spoke to acute nurse practitioner Aurika Savickaite who is helping lead an initiative to educate and raise awareness of the technology.

 

Topics

Related Companies

UsernamePublicRestriction

Register

MT104118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel